COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,906 Articles (22,039 medRxiv, 7,867 bioRxiv)

Most recent first Previous |  Page 6: Articles 51-60  | Next

Neutralizing Activity and Viral Escape of Pemivibart by SARS-CoV-2 JN.1 sublineages
Yao, T., Ma, Z., Lan, K., Guo, Y., Liu, L.
10.1101/2024.11.08.622746 — Posted: 2024-11-10
Generation of a biosafety mouse model infection for SARS-CoV-2 replicon delivery particles
Li, Y., Huang, X., Deng, J., Tan, X., Liu, Q., Zhou, L., Chen, Y.
10.1101/2024.11.10.622838 — Posted: 2024-11-10
Factors associated with lower COVID-19 vaccine uptake among populations with a migration background in the Netherlands
Smagge, B., Labuschagne, L., Pijpers, J., van Roon, A., van den Hof, S., Hahne, S., de Melker, H.
10.1101/2024.11.07.24316886 — Posted: 2024-11-08
Assessment of Vaccine managers' Knowledge and Observance of Vaccination Norms and Standards in an Urban Health District of Yaounde (Cameroon) during the COVID-19 Pandemic
Lekeumo Cheuyem, F. Z., Amani, A., Ajong, B. N., Otsali, R. K. N., Nouko, A., Guissama, E. O., Ngos, C. S., Mohamadou, A., Nloga, G. S., Edzamba, M. F., Bitye Bi Mvondo, E. A., Ntsek, L. L., Mouangue, C., Kissougle Nkongo, F.
10.1101/2024.11.07.24316922 — Posted: 2024-11-08
Adjuvant Recombinant SARS-CoV-2 Spike Protein Vaccine Immunogenicity After Prior mRNA Vaccine Doses
Adelglass, J. M., Bradley, P., Cai, M. R., Chau, G., Kalkeri, R., Cloney-Clark, S., Zhu, M., Cai, Z., Eickhoff, M., Plested, J. S., Mallory, R. M., Dunkle, L. M.
10.1101/2024.11.07.24316865 — Posted: 2024-11-08
Observational Report on Functional SARS-CoV-2 Immune Responses in Immune Competent and Compromised Individuals
Peek, L. J., Patrick, A., Givens, N., DAlessio, B., Weaver, A., Jackson, L., White, T. J., Pestano, G.
10.1101/2024.11.08.24316708 — Posted: 2024-11-08
Relationship between plasma cortisol concentration and Long COVID symptoms in the post-acute phase of COVID-19: a cross-sectional study and recommendations for future research
Dalhuisen, T., Grebe, H., Anglin, K., Lu, S., Goldberg, S. A., Kallas-Silva, L., Hauser, J., Conway, E., Ewing, M., Chen, J. Y., Fehrman, E. A., Kelly, J. D., Martin, J. N., Hunt, P. W., Henrich, T. J., Durstenfeld, M. S., Deeks, S. G., Murphy, E., Schambelan, M., Peluso, M. J.
10.1101/2024.11.07.24316777 — Posted: 2024-11-08
Post-SARS-CoV-2 Onset Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symptoms in Two Cohort Studies of COVID-19 Recovery
Jamal, A., Dalhuisen, T., Gallego Marquez, N., Dziarski, A. D., Uy, J., Walch, S. N., Thomas, S. A., Fehrman, E. A., Romero, A. E., Zelaya, A. S., Akasreku, E. A., Adeagbo, T. V., Pasetes, E. C., Akbas, S. Y., Azola, A. M., Deeks, S. G., Kelly, J. D., Martin, J. N., Henrich, T. J., Landay, A. L., Peluso, M. J., Antar, A. A. R.
10.1101/2024.11.08.24316976 — Posted: 2024-11-08
SARS-CoV-2 JN.1 reveals attenuated pathogenicity and airborne transmission
Liu, R., Jin, Q., Wang, W., Zhang, C., Zhang, H., Li, B., Yan, F., Xia, X., Li, J., Wang, X., Gao, Y.
10.1101/2024.11.07.622580 — Posted: 2024-11-08
Lineage-specific neutralising antibodies after SARS-CoV-2 mild disease. Immune boosting effect of vaccination
Davina-Nunez, C., Perez, S., Cabrera-Alvargonzalez, J. J., Gonzalez-Alonso, E., Silva-Bea, S., Rodriguez-Perez, M., Perez-Gonzalez, A., del Campo, V., Figueroa-Lamas, M. d. P., Rojas, A., Mendoza, J., Regueiro-Garcia, B. J.
10.1101/2024.11.08.622599 — Posted: 2024-11-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).